Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

Fire Needling Added to Standard Needling for Chronic Migraine With Tension-Type Headache

Tests fire needling plus filiform needling in adults with chronic migraine and tension-type headache.

Plain-language title generated from the registry record
Registry title: Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-Type Headache

Key facts

Where
Beijing, ChinaSee the 3 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07633522, who can take part

Where in China

  • Beijing Hospital of Traditional Chinese MedicineBeijing, ChinaNo longer taking part
  • Beijing Tiantan Hospital,Capital Medical UniversityBeijing, ChinaNo longer taking part
  • Capital Medical University Affiliated Beijing Tongren HospitalBeijing, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Beijing Hospital of Traditional Chinese Medicine
Trial code
NCT07633522
Record updated
8 June 2026
Original description
The investigators conducted a multicenter, prospective, randomized controlled clinical study to learn whether fire needling combined with filiform needling applied to pericranial muscle tenderness areas can effectively treat chronic migraine with comorbid tension-type headache. The study will also evaluate the safety and long-term efficacy of this therapy. Its main target questions include:Read full original descriptionShow less

Clinical Research on Fire Needling Combined With Filiform Needling for Chronic Migraine With Comorbid Tension-type Headache

The investigators conducted a multicenter, prospective, randomized controlled clinical study to learn whether fire needling combined with filiform needling applied to pericranial muscle tenderness areas can effectively treat chronic migraine with comorbid tension-type headache. The study will also evaluate the safety and long-term efficacy of this therapy. Its main target questions include:

1. Can fire needling significantly reduce the number of headache days per month? 2. What is the effect of this therapy on headache intensity, emotional symptoms, and quality of life? The investigators will compare "fire needling at pericranial tender points plus conventional filiform needling" versus "conventional filiform needling alone" to verify whether the key technique of fire needling plus conventional filiform needling provides unique additive value.

Participants will:

1. Receive treatment twice per week for 8 weeks (either in the experimental group or the control group),attend a follow-up visit at week 24 after enrollment 2. Keep a headache diary (recording headache frequency, pain intensity, duration, associated symptoms, etc.) 3. Regularly complete assessments of emotional status, quality of life, and number of pericranial tender points

Inclusion: Meets the diagnostic criteria for tension-type headaches with pericranial tenderness; Meets the diagnostic criteria for chronic migraine; 18 years ≤ age ≤ 65 years; Has sufficient understanding to complete the necessary examinations and tests for the study; Voluntarily joins this study and signs the informed consent form.

Exclusion: Patients with alcohol or drug dependence; Patients who have received acupuncture treatment within 3 months prior to enrollment; Patients with secondary headaches caused by intracranial space-occupying lesions, cranial infections, etc; Patients complicated with severe heart, liver or kidney impairment, coagulation disorders, infections, severe immunocompromise, or allergic predisposition; Patients complicated with cluster headache or other primary headaches; Patients who are unable to cooperate with acupuncture treatment; Women who are planning pregnancy, pregnant or breastfeeding.

ClinicalTrials.gov NCT07633522